Molecular Mechanism of Chronic Viral and Non-Viral Liver Diseases

por Kanda, Tatsuo
Publicado 2023

The androgen receptor as an emerging target in hepatocellular carcinoma

por Kanda, Tatsuo, Yokosuka, Osamu
Publicado 2015

Direct-acting antiviral agents against hepatitis C virus and lipid metabolism

por Kanda, Tatsuo, Moriyama, Mitsuhiko
Publicado 2017

Treatment of hepatitis C virus infection in the future

por Kanda, Tatsuo, Yokosuka, Osamu, Omata, Masao
Publicado 2013

Hepatitis C Virus and Hepatocellular Carcinoma

por Kanda, Tatsuo, Yokosuka, Osamu, Omata, Masao
Publicado 2013

Faldaprevir for the Treatment of Hepatitis C

por Kanda, Tatsuo, Yokosuka, Osamu, Omata, Masao
Publicado 2015

Hepatitis A Virus Infection and Molecular Research

por Kanda, Tatsuo, Sasaki-Tanaka, Reina, Nakamoto, Shingo
Publicado 2022

Impact of Rechallenge with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib

por Sawaki, Akira, Kanda, Tatsuo, Komatsu, Yoshito, Nishida, Toshirou
Publicado 2014

New treatments for genotype 1 chronic hepatitis C – focus on simeprevir

por Kanda, Tatsuo, Nakamoto, Shingo, Wu, Shuang, Yokosuka, Osamu
Publicado 2014

A semi–supervised tensor regression model for siRNA efficacy prediction

por Thang, Bui Ngoc, Ho, Tu Bao, Kanda, Tatsuo
Publicado 2015

S1-induced vasospastic angina—diagnostic utility of Holter ECG: a report of a case

por Kanda, Tatsuo, Wakai, Atsuhiro, Chida, Tadasu, Nakamura, Yuichi
Publicado 2020

Recurrence hernia in the broad ligament of the uterus: a case report

por Hashimoto, Yoshifumi, Kanda, Tatsuo, Chida, Tadasu, Suda, Kazuyoshi
Publicado 2020

Knockdown of MBP-1 in Human Foreskin Fibroblasts Induces p53-p21 Dependent Senescence

por Ghosh, Asish K., Kanda, Tatsuo, Steele, Robert, Ray, Ratna B.
Publicado 2008

Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response

por Sasaki, Reina, Kanda, Tatsuo, Kato, Naoya, Yokosuka, Osamu, Moriyama, Mitsuhiko
Publicado 2018

Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review

por Kanda, Tatsuo, Goto, Taichiro, Hirotsu, Yosuke, Moriyama, Mitsuhiko, Omata, Masao
Publicado 2019

Follow-Up of Patients Who Achieved Sustained Virologic Response after Interferon-Free Treatment against Hepatitis C Virus: Focus on Older Patients

por Nirei, Kazushige, Kanda, Tatsuo, Masuzaki, Ryota, Mizutani, Taku, Moriyama, Mitsuhiko
Publicado 2021

Molecular Mechanisms, Diagnosis and Treatments in Digestive Malignancy

por Kanda, Tatsuo, Masuzaki, Ryota, Sasaki-Tanaka, Reina, Kogure, Hirofumi, Moriyama, Mitsuhiko
Publicado 2023

Analysis of 5′ Nontranslated Region of Hepatitis A Viral RNA Genotype I from South Korea: Comparison with Disease Severities

por Kanda, Tatsuo, Jeong, Sook-Hyang, Imazeki, Fumio, Fujiwara, Keiichi, Yokosuka, Osamu
Publicado 2010

Akt inhibitor augments anti-proliferative efficacy of a dual mTORC1/2 inhibitor by FOXO3a activation in p53 mutated hepatocarcinoma cells

por Patra, Tapas, Meyer, Keith, Ray, Ratna B., Kanda, Tatsuo, Ray, Ranjit
Publicado 2021

Favipiravir Inhibits Hepatitis A Virus Infection in Human Hepatocytes

por Sasaki-Tanaka, Reina, Shibata, Toshikatsu, Okamoto, Hiroaki, Moriyama, Mitsuhiko, Kanda, Tatsuo
Publicado 2022